Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Newswire Search Past 90 Days 1 stories 1 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View
Related Topics
Topic # Mentions Topic Reach
Prominent Journalists
Byline Articles Written Avg Reach
MingMed Biotechnology Co., Ltd 1 -


MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
MingMed Biotechnology Co., Ltd — avpress.com

Execution: 0.11 Seconds. 47.5 mb used.